February 23, 2021
HGH, the world-renowned specialist in electro-optics is pleased to announce that Jeffrey Anderson has been promoted to President of Electro Optical Industries, Inc. (EOI), HGH’s US subsidiary. EOI was acquired by HGH Infrared Systems in 2016 and will become HGH USA under Anderson’s leadership. Anderson’s promotion coincides with that of Vincent Leboucher, who was recently promoted to lead the HGH Group following the retirement of President Thierry Campos after 32 years at the company.
Anderson joined EOI as the General Manager in 2019, bringing to HGH extensive experience in optical sciences, systems engineering as well as technical leadership from his time at Lockheed Martin, Teledyne Scientific & Imaging, and L3Harris Technologies. With investments from HGH, Anderson has spearheaded numerous R&D initiatives and product innovations including the rapid development and deployment mIRcury®, a crowd temperature screening solution to help fight the COVID-19 pandemic.
Regarding Anderson’s promotion, Brent Lindstrom, Director of Sales at EOI, commented that “The past year at EOI has seen more innovation, more new products, and unprecedented business development growth than at any time in the past decade. The new EOI leadership and many new talented EOI Team members are helping drive this new success by expanding our R&D capabilities as well as our Engineering, Design, and Production Staff. We are poised to duplicate this success again in 2021.” EOI’s team in Goleta, California has doubled in size in the last year and released several new products.
“Congratulations to Jeff and his promotion to EOI president. This is an exciting time for EOI with Jeff’s new vision, passion, leadership and innovation, all things are possible,” says Mike Moschitto, Sr. Operations Manager at EOI, expressing the EOI team’s enthusiasm for expanding the company’s operations and product offering. Since 1964, EOI has been the leader in photonics test equipment and standards, and is excited to bring to customers in the US HGH’s innovative technologies, including its flagship Wide Area Surveillance product line, SPYNEL.
“Since his recent arrival, Jeff gave a lot of energy in strengthening a highly skilled and motivated team making HGH USA a major entity of the group. He succeeded very quickly, launching new products, promoting the manufacturing in the USA, developing the business and signing strategic contracts. In a very complex COVID-19 context, Jeff changed difficulties into success. Both engineers, we share the same innovation culture. With two legs the group will run faster and faster,” says Vincent Leboucher, President of HGH Group.
HGH, under new management, will continue to focus on its core value of innovation. Despite the difficulties posed by the COVID-19 pandemic, HGH continues to see growth year after year, driven by HGH’s investments in R&D. HGH is headquartered in Igny, France but has a growing worldwide presence with offices in California, China, Singapore and India. Globally, R&D represents one third of all HGH employees. With outstanding R&D in end-to-end systems and software as well as product innovations, the HGH management team anticipates many future growth opportunities in the areas of Wide Area Surveillance, Test & Measurement, and Industrial Thermography.
HGH has been an expert in infrared technology for over 40 years. HGH designs, develops, assembles and sells elctro-optics systems and software for security, defense, oil & gas, energy, and industrial applications. The company has established itself as an international reference for innovation in infrared technology through the development of multiple advanced sensors, systems and proprietary software. HGH's Head Office is located in Igny near Paris-Saclay, and has a strong presence in the USA with a main office in Goleta, CA and in Asia through Asia Infrared Systems Pte Ltd.
For more information, visit us at www.electro-optical.com.